Bicycle Therapeutics Plc ADR’s recently made public that its CHIEF PROD & SUPPLY CHAIN OFF Hannay Michael Charles Ferguso unloaded Company’s shares for reported $5780.0 on Apr 11 ’24. In the deal valued at $22.49 per share,257 shares were sold. As a result of this transaction, Hannay Michael Charles Ferguso now holds 22,891 shares worth roughly $0.46 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Lee Kevin sold 3,158 shares, generating $75,192 in total proceeds. Upon selling the shares at $23.81, the CHIEF EXECUTIVE OFFICER now owns 387,270 shares.
Before that, Crockett Nigel sold 955 shares. Bicycle Therapeutics Plc ADR shares valued at $22,739 were divested by the CHIEF BUSINESS OFFICER at a price of $23.81 per share. As a result of the transaction, Crockett Nigel now holds 47,761 shares, worth roughly $0.96 million.
B. Riley Securities upgraded its Bicycle Therapeutics Plc ADR [BCYC] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Cowen’s analysts, who began to cover the stock in late August with a ‘”an Outperform”‘ rating. Barclays began covering BCYC with “an Overweight” recommendation on July 28, 2022.
Price Performance Review of BCYC
On Tuesday, Bicycle Therapeutics Plc ADR [NASDAQ:BCYC] saw its stock fall -2.58% to $20.02. Over the last five days, the stock has lost -9.41%. Bicycle Therapeutics Plc ADR shares have risen nearly 10.73% since the year began. Nevertheless, the stocks have fallen -20.87% over the past one year. While a 52-week high of $27.50 was reached on 02/28/24, a 52-week low of $12.54 was recorded on 01/05/24. SMA at 50 days reached $22.64, while 200 days put it at $20.17. A total of 0.13 million shares were traded, compared to the trading of 0.25 million shares in the previous session.
Levels Of Support And Resistance For BCYC Stock
The 24-hour chart illustrates a support level at 19.77, which if violated will result in even more drops to 19.52. On the upside, there is a resistance level at 20.49. A further resistance level may holdings at 20.95. The Relative Strength Index (RSI) on the 14-day chart is 34.28, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.95, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 99.40%. Stochastics %K at 7.44% indicates the stock is a buying.
